Medtech stories we missed this week: Nov. 17, 2017

From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics.

How a versatile epoxy is enabling brain stimulation

In but another example of how useful and critical epoxies can be, researchers in Israel used a two-part epoxy to construct a magnetic coil to stimulate animal brain neurons via a magnetic field. Rohit Ramnath, Master Bond Designers of medical electronics assemblies have many options to choose from when selecting one or more compounds for

Medtech stories we missed this week: July 21, 2017

From Second Sight’s South Korean market entry to Sanuwave’s Indonesian distribution deal, here are medtech stories we missed this week but thought were still worth mentioning. 1. Second Sight enters South Korea market Second Sight announced in a July 5 press release that it has entered the market in South Korea with the implantation of two

Medtech stories we missed this week: July 14, 2017

From Novarad touting its VR-surgical guidance system to Zynex paying off its $2.2M loan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Stimwave announces first patient in Brazil Stimwave announced in a July 5 press release that its first patients in Brazil have received Stimwave’s wireless pain relief

Philips is bringing augmented reality to surgery: Here’s how

Royal Philips, a leader in integrated image-guided therapy solutions, has developed an augmented-reality (AR) surgical navigation technology. The new technology is designed to help surgeons perform image-guided open and minimally-invasive spine surgery. Philips has 750 hybrid operating rooms installed worldwide to assist with surgical and minimally-invasive endovascular procedures. These hybrid OR solutions paired with the

Nonin Medical launches next generation LifeSense II and RespSense II Capnographs

Nonin Medical, the inventor of finger pulse oximetry and a developer in noninvasive medical monitoring, announced it has launched the next generation of end-tidal CO2 monitors in the LifeSense II capnograph/pulse oximeter and RespSense II capnograph. The Nonin LifeSense II and RespSense II are value-priced monitors that are ideal for a wide range of medical monitoring

CNOGA Medical appointed ARTECH to distribute their non-­invasive medical devices in Italy

CNOGA Medical, a developer and manufacturer of non-­invasive medical monitoring device, is pleased to announce that they have signed a distribution agreement with ARTECH S.R.L. CAVEZZO MO, Italy to distribute CNOGA’s Tensor TipTM Non­invasive devices in Italy. The MTX non­invasive device, from CNOGA’s Tensor TipTM Family, is capable of monitoring 14 parameters, such as blood

PathMaker Neurosystems announces key patent issuance by U.S. Patent and Trademark Office for fundamental technology covering MyoRegulator

PathMaker Neurosystems, a clinical-stage neurotechnology company developing non-invasive neurotherapy systems for the treatment of patients with neuromotor disorders, announced that the U.S. Patent and Trademark Office has granted a fundamental patent (U.S. Patent 9,283,391) covering its proprietary DoubleStim technology that forms the basis of our MyoRegulator system, a first-in-class non-invasive device now in human clinical trials

Spineology introduces new Palisade Pedicular Fixation System at AANS

Spineology, an innovator in anatomy-conserving surgery, announces the full U.S. market release of its Palisade Pedicular Fixation System. The Palisade Pedicular Fixation System is designed to minimize surgical invasiveness and enhance efficiency. The integrated break-off screw extensions and quick-start screw design minimize procedural steps and limit tissue disruption during screw insertion and rod placement. “Palisade is the

PathMaker Neurosystems and Feinstein Institute announce initiation of first clinical trial of MyoRegulator to treat muscle contraction

PathMaker Neurosystems Inc., a clinical-stage neurotechnology company developing non-invasive neurotherapy systems for the treatment of patients with neuromotor disorders, recently announced that it has launched an Institutional Review Board (IRB)-approved human clinical trial in conjunction with Northwell Health (formerly North Shore-LIJ Health System) and The Feinstein Institute for Medical Research to evaluate the safety and

Surgical tools made smaller with origami to make surgery less invasive

BYU mechanical engineering professors Larry Howell and Spencer Magleby have made a name for themselves by applying the principles of origami to engineering. Now they’re applying their origami skills to a new realm: the human body. The duo, along with professor Brian Jensen and their students, are working toward surgical technology that will allow for

U-M researchers find non-invasive way to view insulin in pancreas

“Scientists and doctors have wanted to know how much insulin a person has in their body, but haven’t been able to know the exact amount without the patient being deceased and actually removing the pancreas,” said Peter Arvan, division chief of Metabolism, Endocrinology & Diabetes at the University of Michigan. But a new study in

OrthoGrid Systems announces the new HipGrid Drone

OrthoGrid Systems recently announced the release of the new HipGrid Drone at the American Association of Hip and Knee Surgeons (AAHKS) 25th Annual Meeting held in Dallas last November (2015). The new Drone delivery system incorporates the popular HipGrid for direct anterior and posterior approach total hip arthroplasty (THA), improves ease of use for both surgeons and

electroCore is enrolling patients for two double blind migraine studies

Having successfully completed three studies of non-invasive vagus nerve stimulation (nVNS) for prevention and treatment of cluster headache, electroCore is now expanding its clinical program with two new trials of its gammaCore nVNS therapy in episodic migraine. The first trial is focused on the prevention of migraine, and the second examines the efficacy of nVNS

Simple test allows for rapid diagnosis of preeclampsia

Researchers have found that a simple test can rapidly detect one of the world’s most deadly pregnancy-related conditions, which could have a major impact on global health. Preeclampsia, which affects 5 to 8% of pregnancies worldwide, is characterized by high blood pressure and protein in the urine. The disorder is the number one reason physicians